Animals were anesthetized with a mixture of ketamine (100 mg/kg, i.p., Bayer Pharma, Lyon, France) and xylazine (15 mg/kg, i.p., Merial, Lyon, France) and surgically prepared with an indwelling ...

Glyphosate-based Roundup is widely used in US farming Bayer paid about $10 bln to settle, billions more at risk German group has lobbied US lawmakers for legal relief Source: Bayer could reach a ...

FRANKFURT (Reuters) -Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation, according to a ...

FRANKFURT, March 4 (Reuters) - Bayer's CEO (BAYGn.DE), opens new tab is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline this year ...

BERLIN (Reuters) -Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's ...

Elon Musk addresses recent scrutiny regarding his ketamine use, asserting it is medically supervised and aids in managing depression. Though linked to hallucinogenic effects, Musk claims his ...

Authorities confirm an arson investigation in Madison. Global pharma giant Bayer confirms "an incident" at one of their executive's homes. Bayer's U.S. HQ is located nearby in Hanover. New Jersey ...

Last year marked the beginning of a massive corporate overhaul at Bayer, and along with that restructuring came a year-over-year pay cut for the German conglomerate’s CEO. In 2024, Bayer CEO ...

Ketamine is called a dissociative drug because during a high, which lasts about an hour, people might feel detached from their body, their emotions, or the passage of time. Frequent, heavy ...

Bayer AG’s shares dropped after the German conglomerate was ordered by a jury in the US state of Georgia to pay almost $2.1 billion to a plaintiff who claimed its Roundup weedkiller caused ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the company’s pharma division was able to eke out modest sales gains of ...